JDOC ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
LLY	F	-0.25	8.80
UNH	C	-1.11	8.71
TMO	F	-0.55	4.58
ABBV	D	3.04	4.17
DHR	F	0.34	3.86
BSX	B	-1.64	3.46
REGN	F	-0.87	3.18
MCK	B	-0.81	2.94
SYK	C	-1.36	2.77
BMY	B	1.10	2.76
VRTX	F	0.13	2.69
MDT	D	1.73	2.54
CI	F	-0.49	2.46
JNJ	D	-0.21	2.36
ISRG	A	-0.50	1.65
HCA	F	-2.20	1.62
MRK	F	-0.68	1.60
IQV	D	2.14	1.19
WST	C	-1.34	1.00
EXAS	D	-0.30	0.90
NTRA	B	-1.24	0.85
CNC	D	0.03	0.83
DXCM	D	-2.19	0.81
AGIO	C	0.25	0.79
HALO	F	7.22	0.78
ITCI	C	0.28	0.77
NBIX	C	0.52	0.76
AMGN	D	1.60	0.71
INSP	D	1.36	0.69
HUM	C	0.81	0.69
BPMC	C	-2.56	0.60
SRPT	D	3.38	0.59
RVMD	C	-0.05	0.56
NVS	D	0.41	0.55
BMRN	D	1.28	0.55
TWST	D	1.37	0.52
BIIB	F	-0.07	0.46
IRTC	D	0.12	0.42
ACHC	F	-0.93	0.41
ALNY	D	-0.77	0.38
APLS	D	10.88	0.33
ARVN	D	2.99	0.28
EVH	F	-2.93	0.26
IDXX	F	-0.31	0.20

Represented by ETF Holdings

Keywords: S&P 500 Medicine Biopharmaceutical Biotechnology Life Sciences Nasdaq 100 Cancer Diabetes Clinical Medicine Infectious Diseases Mental Health Pharmaceutical Products Antibiotics Autoimmune Disease Bone Clinical Development Depressive Disorder Dow Jones Component Lab Testing Medicaid

Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Health Care Plans Medical Devices Medical Instruments & Supplies Medical Care Health Information Services Medical Distribution

Recent News for JPMorgan Healthcare Leaders ETF & its Holdings

Date	Stock	Title
Nov 23	VRTX	3 Monster Stocks in the Making
Nov 23	MRK	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 23	JNJ	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 23	TMO	Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22	LLY	Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22	MRK	Merck recommends rejection of TRC Capital’s 'mini-tender' offer
Nov 22	ABBV	AbbVie gains on Leerink Partners upgrade to Outperform
Nov 22	MRK	Merck Recommends Rejection of TRC Capital’s "Mini-Tender" Offer
Nov 22	CI	Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Nov 22	EVH	Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Nov 22	HUM	Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Nov 22	HCA	Hospital Stocks Drop as Raymond James Cuts on Funding Risks
Nov 22	ABBV	AbbVie: Upgrading To 'Strong Buy' After Pullback
Nov 22	NVS	Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
Nov 22	ACHC	Is Now An Opportune Moment To Examine Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Nov 22	DHR	Danaher Corp (NYSE:DHR): A Bullish Investment Perspective
Nov 22	JNJ	Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22	CI	Looking Into Cigna's Recent Short Interest
Nov 22	NVS	Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Nov 22	SRPT	High Growth Tech Stocks to Watch in November 2024

The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Biotechnology Venture Capital Medical Technology Healthcare Service Healthcare Technology

ETF Components for JDOC - JPMorgan Healthcare Leaders ETF